Macrophage-tropic, non-syncytium-inducing, HIV-1 variants predominate in the asymptomatic phase of infection and may be responsible for establishing infection in an individual exposed to the mixture of HIV-1 variants. Here, genotypical and phenotypical characteristics of virus populations, present in sexual, parenteral, or vertical donor-recipient pairs, were studied. Sequence analysis of the V3 domain confirmed the presence of a homogeneous virus population in recently infected individuals. Biological HIV-1 clones were further characterized for syncytium inducing capacity on the MT2 cell line and for macrophage tropism as defined by the appearance of proviral DNA upon inoculation of monocyte-derived macrophages. Both sexual and parenteral transmission cases revealed a selective outgrowth in the recipient of the most macrophage-tropic variant(s) present in the donor. In three out of five vertical transmission cases, more than one highly macrophage-tropic virus variant was present in the child shortly after birth, suggestive of transmission of multiple variants. In three primary infection cases, homogeneous virus populations of macrophagetropic, non-syncytium-inducing variants were present prior to seroconversion, thus excluding humoral immunity as the selective pressure in favour of macrophage-tropic variants. These observations may have important implications for vaccine development. (J. Clin. Invest. 1994. 94
Introduction
Human immunodeficiency virus type I (HIV-1) isolates can display differences in biological properties such as syncytium 5) . T cell line-tropic SI HIV-1 variants appear during the asymptomatic phase of infection in about 50% of infected individuals and are associated with accelerated CD4+ cell decline and more rapid progression to AIDS (6) . In contrast, in the early asymptomatic phase in general only non-syncytium-inducing (NSI) HIV-1 variants are present, which, unlike SI HIV-1 variants, are highly macrophage tropic (7) . These macrophagetropic NSI variants persist during all stages of infection, even after the emergence of SI variants (7, 8) , indicating their importance for viral persistence. The appearance of SI variants in later stages of infection in about half of the infected individuals would suggest the presence of SI variants in at least some individuals that may be involved in HIV-1 transmission. However, in more than 95% of recently HIV-1-infected individuals only NSI variants are detected (5, 9) . It has been suggested that at the time of primary infection cotransmitted SI variants are immediately cleared from the body by the immune system, due to their high level of replication (10) (11) (12) . In the described cases, however, this clearance was transient and may not explain the absence of SI variants in the majority of HIV-1 -infected individuals.
Several groups have analyzed envelope sequences of virus populations present during primary infection. The identification of specific amino acid residues in the third variable domain (V3) of the HIV-1 envelope gpl2O molecule as major determinants for SI capacity and macrophage tropism (13) (14) (15) provided the possibility for a biologically significant interpretation of available sequence data. The V3 sequences of HIV-1 variants present around the moment of seroconversion all show a remarkable homology with sequences that are characteristic for macrophage-tropic NSI viruses (16) (17) (18) . In these studies the biological phenotype of HIV-1 clones was deduced from the sequence and was not tested in biological assays. However, the selection of macrophage-tropic or NSI variants upon sexual transmission has indeed been reported (19) . In the present study we performed genotypical and phenotypical analyses of virus populations present in donor-recipient pairs between whom sexual, parenteral, or vertical transmission of HIV-1 was documented. Moreover, the clonal composition of HIV-1 populations present at the time of seroconversion following sexual transmission was studied. PCR and sequence analysis. Total DNA from PBMC harboring the biological HIV-1 clones was isolated as described (21) . V3 sequences were amplified by PCR as described (22) . Products were purified with a Geneclean kit (BIO 101, Inc. Vista CA), and sequenced directly using the dideoxy chain termination method with Sequenase (USB, Cleveland, OH), both according to instructions from the manufacturers.
Methods
Macrophage-tropism ofHIV-I clones. About 50% of primary HIV-1 variants completely lack macrophage tropism (7, 23) . These variants are restricted at an early step of the viral replication cycle, presumably entry (24) . Their non-macrophage tropism is determined by the viral envelope (25, 26 (21) , amplified in a nested PCR amplifying the p24 region of gag (27) , and reaction products were analyzed by agarose gel electrophoresis. No PCR products were obtained from the zidovudine-treated controls. MDM from one to four seronegative blood donors were tested with each virus stock. For the analysis of macrophage tropism, MDM from the same blood donors were used for all the HIV-1 clones derived from one donorrecipient couple. Macrophage tropism of HIV-1 variants is defined as the percentage of MDM cultures that show evidence of proviral DNA: 0%, -; 1-25%, ±; 26-50%, +; 51-75%, ++; and 76-100%, +++.
Results
Clonal HIV-1 populations in donors and recipients of two homosexual transmission cases. From both donors and recipients in two homosexual transmission cases phenotype and genotype of clonal virus populations, present around the time point of seroconversion of the recipient, were analyzed. Biological clones, isolated on PHA-stimulated PBMC, were analyzed for SI capacity and macrophage-tropism and, in addition, V3 sequence analysis was performed. The results are depicted in Table I . From donor ACH486 both SI and NSI clones were obtained 3 and 12 mo after the seroconversion date of recipient ACH491. Virus clones with the SI phenotype constituted 76% of the total virus population at the 12-mo time point. From the recipient, only NSI clones were obtained. V3 loop sequence analysis was performed on seven SI and seven NSI clones from the donor and on two NSI clones from the recipient. These two NSI clones had identical V3 loop sequences (sequence 9) that showed highest homology to the NSI clones present in donor ACH486 (sequences 2, 3, 7, and 8). When tested for macrophage tropism on MDM from four different donors these NSI variants appeared to be the most macrophage-tropic virus variants present in the donor.
In the second homosexual transmission case only NSI HIV-1 clones were obtained from both donor and recipient. The major variant present in donor ACH455 (sequence 1) was also detected in recipient ACH1 140. When the HIV-1 clones from donor ACH455, representing three variants with genotypically distinct V3 domains, were tested for their macrophage-tropism, the virus clones with highest homology to the HIV-1 clone isolated from recipient ACHI140, most efficiently infected MDM from the four different donors tested.
Composition ofHIV-I populations in donors and recipients of two parenteral transmission cases. In the first parenteral transmission case, the recipient (HIVA,,.127) was exposed to a minute amount of blood from a patient (ACH704) with wasting syndrome CDC IVa (20) . A total of 11 clones were obtained from the donor of which five clones had the SI and six clones had the NSI phenotype (Table HI ). All NSI clones were able to replicate in MDM to some extent, whereas only one of the SI clones (sequence 4) was macrophage-tropic. Interestingly, this macrophage-tropic SI clone was the only virus variant present upon infection of recipient HIVAms 127, possibly due to the low inoculum size. Biological clones from recipient HIVAmS127 were obtained on PHA-stimulated PBL as well as on MDM (8) .
Both methods yielded clones with exactly the same V3 loop compatible with the presence of a clonal virus population. Shortly after seroconversion of the recipient all clones were macrophage-tropic, but after 5.5 mo none of the clones isolated on PHA-stimulated PBL were macrophage-tropic, possibly reflecting evolution to T cell-tropic viruses.
In the second parenteral transmission case, the recipient (ACH9012) was exposed to a few milliliters of blood from an HIV-J Macrophage-tropism and Transmission 2061 
SC, seroconversion; D, donor; R, recipient; no., sequence number; n, number of clones; SI phenotype was determined by cocultivation with the MT2 cell line, * Number of macrophagetropic clones from the total number of clones with that particular V3 loop, each column represents results obtained with MDM from one blood donor A, B, C, and D. * As defined in Methods; nt, not tested. Clonal HIV-J populations in mothers and children involved in vertical transmission. Five mother-child pairs (Table III) , between whom HIV-1 transmission was documented, were studied. In pair 114 intrauterine transmission was proven, based on the presence of virus in umbilical cord blood samples, where contamination with maternal blood could be ruled out (28 5, 6 , and 7) present in the mother 9.5 mo after delivery, but not 1.5 mo before delivery. In three cases (114, 127, and 133), several variants present in the children were also detected in their mothers before delivery, suggestive of transmission of multiple clones. All variants present in M127 2 wk before delivery were detected in child C127, either in PBMC obtained 10.5 mo after birth or in serum taken 6 wk after birth (sequence 4, G. A. Mulder-Kampinga, unpublished observation). The major variant in C127 (sequence 5) was not detected in mother M127 either 7 or 0.5 mo before birth.
Clonal HIV-J populations present around the moment of seroconversion. To determine at which level selection for macrophage-tropic variants occurs, we analyzed biological clones obtained during viremia occurring at the time of seroconversion (Table IV) . For each of the three individuals tested, virus populations were extremely homogeneous in V3, already prior to seroconversion, which is in agreement with previous studies (16, 17) . In one individual (scB), sequence diversification was first shown after more than one year following seroconversion. All virus clones were of the NSI phenotype and had the corresponding genotype. Moreover, cell free infection of MDM indicated that the majority of these clones was highly macrophage tropic.
Discussion
In the course of asymptomatic HIV-1 infection T cell linetropic SI HIV-1 variants develop in about 50% of infected people. NSI HIV-1 variants are present during all stages of infection even after the emergence of SI HIV-1 variants. Although both NSI and SI HIV-1 clones can be transmitted (11, 29, 30) , in 95% of recently infected individuals only NSI HIV-1 clones can be detected (5, 9) . Several groups (16) (17) (18) have found that the amino acid sequences of the V3 loop of virus populations, present during primary infection in an individual, are very homogeneous and remarkably homologous to sequences characteristic for macrophage-tropic NSI viruses (13) (14) (15) . Clonal analysis of V3 sequences of HIV-1 in documented transmission cases showed that viruses in the recipients had the NSI genotype, even when viruses with SI-type V3 sequences were present in the donor (31 In the present study, in one parenteral (donor HIVA,,s 199 and recipient ACH9012) and in three vertical (114, 127, and 133) transmission cases, more than one of the HIV-1 variants detected in the donors were present in the cognate recipients. There were up to six amino acid differences in V3 sequences between the different SI and NSI HIV-1 clones detected in recipient ACH9012 and four amino acid differences between the two NSI HIV-1 clones in child C133. This variation is too large to assume parallel evolution of HIV-1 clones in both donor and recipient. The NSI HIV-1 clones from the other children (114 and 127) differed by only one amino acid. Sequencing additional regions in the biological clones from these motherchild pairs may show whether the minor variant in the child either has evolved from the major HIV-1 variant in the child or was transmitted simultaneously. Transmission of multiple HIV-1 variants via the vertical route has previously been suggested (33) and may be related to the long exposure time in utero or to the large inoculum to which the newborn may be exposed during delivery. (41) . This would thus also exclude CTL activity against V3 as the selective pressure in favor of macrophage-tropic variants.
These observations favor selection at the level of the first target cell. The selective elimination of SI variants in recipient ACH9012 of one of the parenteral transmission cases, however, points to selective pressure in favor of macrophage-tropic NSI variants also after establishment of infection, as suggested previously (10, 11) . This relatively late selection may be directed by immune control. In the asymptomatic phase of HIV-1 infection the presence of high neutralizing antibody titers may allow virus transmission only during direct cell to cell contact, as would occur between macrophages and T cells during noncognate adhesion or cognate antigen presentation. The observation that peripheral blood T cells in this phase of infection carry only macrophage-tropic viruses (7, 42) is indeed indicative for recent infection of these T cells by progeny from HIV-1 infected macrophages. The emergence of non-macrophage-tropic SI variants in general only at a stage where CD4' cell numbers are decreased and T cell function is affected (6) 
